Kanbi  Pharma  Teknoloji  Limite
321839-75-2 CrineCerfont

321839-75-2 CrineCerfont

Non pwodwi: CrineCerfont
CAS: 321839-75-2
MF: C27H29CL2FN2OS
MW: 519.5
Einecs:
MDL No.:MFCD05260970

Voye rechèch
Dekri teren

Pwopriyete

Aparans limyè jòn poud jòn
Depo tanperati. 4 degre, lwen imidite ak limyè

 

Aplikasyon:

CrineCerfont (SSR -125543) se yon efikas oral aktif, ki pa peptides antagonist reseptè CRF1 prensipalman itilize pou tretman nan konjenital hyperplasia adrenal (CAH). Crinecerfont inibit sekresyon pitwitèr nan òmòn adrenokortikotwopik (ACTH) pa bloke obligatwa nan kortikotropin divilge faktè (CRF) nan reseptè CRF1 nan glann pitwitèr la, kidonk diminye ACTH medyatè adrenal pwodiksyon androjèn ak ede kontwole akrojèn nan adrenal adrenal adrenal ak adrenal nan plis
 

 

Sinonim:

321839-75-2

Crinecerfont (hydrochlorid)

4- (2- chloro -4- methoxy -5- methylphenyl) -n-[(1s) -2- cyclopropyl -1- (3- fluor {{}} } methylphenyl) etil] -5- methyl-n-prop -2- ynyl -1, 3- thiazol -2- amine; hydrochloride

(S) -4- (2- chloro -4- methoxy -5- methylphenyl) -n-(2- cyclopropyl -1- (3- } fluoro -4- methylphenyl) etil) -5- methyl-n- (prop -2- ynyl) thiazol -2- amine idroklorur

4- (2- chloro -4- methoxy -5- methylphenyl) -n-[(1s) -2- Cyclopropyl -1- (3- Fuuor o -4- methylphenyl) etil] 5- methyl-n-(2- propynyl) -1, 3- thiazol -2- amine idroklorur

 

 

Baj popilè: 321839-75-2 CrineCerfont, Lachin 321839-75-2 Konpayi fabrikasyon CrineCerfont, Swèd

Inquiry
goTop

(0/10)

clearall